Brain Computer Interface Training After Stroke

NCT ID: NCT04071587

Last Updated: 2022-11-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-26

Study Completion Date

2022-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, we want to examine the effect of a new treatment approach for patients with severe upper limb paresis in the subacute phase after stroke. Brain Computer Interface (BCI) driven functional electrical stimulation will be compared to conventional training.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A randomized controlled pilot study will be conducted. Forty patients with severe UL paresis will be included. Patients with severe hemiparesis after stroke will be allocated to one of two treatment groups by a computerized randomization program. Patients in the intervention group will receive training with a BCI system paired with functional electrical stimulation and visual feedback (RecoveriX, gtec, Austria) as part of their rehabilitation. The targeted number of training sessions in the intervention group is 12. Patients in the control group will receive conventional upper limb training. All patients will receive other rehabilitation according to their needs.

Patients will be assessed by blinded raters before and after the intervention and 3 months post stroke. Main endpoint will be UL motor function assessed by Action Research Arm Test (ARAT) at 3 months post stroke. Other outcome measures comprise Fugl Meyer Motor Assessment and Functional Independence Measure. The patients and therapists' experience with this type of training will be evaluated with questionnaires and interviews.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients are randomized to one of two treatment options, intervention or standard rehabilitation
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
All assessments will be done by assessors blinded to treatment allocation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BCI training

Patients randomized to this group will receive up to12 (minimum 8) sessions of BCI training with the RecoveriX system (gtec, Austria). The system combines EEG driven functional electrical stimulation with visual feedback. BCI training is provided as a part of standard training of the impaired upper limb.

Group Type EXPERIMENTAL

Brain Computer Interface training

Intervention Type DEVICE

Training with RecoveriX system.

Control

Patients randomized to this control group will receive standard physiotherapy and occupational therapy for their impaired upper limb.

Group Type ACTIVE_COMPARATOR

Control

Intervention Type BEHAVIORAL

Standard physiotherapy and occupational therapy according to clinical routines.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Brain Computer Interface training

Training with RecoveriX system.

Intervention Type DEVICE

Control

Standard physiotherapy and occupational therapy according to clinical routines.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* First ever or former stroke without UL motor residuals as confirmed by CT and / or MRI
* 15 days to 60 days (+/- 3) after stroke onset
* Severe paresis or paralysis defined as \< 13 on Action Research arm Test (ARAT)
* Able to give informed consent
* Able to comply with treatment protocol.

Exclusion Criteria

* Other conditions limiting functional use of the affected UL,
* Psychiatric / behavioral conditions that interfere with compliance to the protocol, epilepsy
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hammel Neurorehabilitation Centre and University Research Clinic

OTHER

Sponsor Role collaborator

Sygekassernes Helsefond

OTHER

Sponsor Role collaborator

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Iris Brunner, PhD

Role: PRINCIPAL_INVESTIGATOR

Aarhus University, Hammel Neurocenter

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hammel Neurorehabilitation Centre and University Research Clinic

Hammel, Aarhus, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

649780

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

BCI Post-stroke Neurorehabilitation
NCT02404857 COMPLETED NA
Hand Rehabilitation Study for Stroke Patients
NCT03148106 ACTIVE_NOT_RECRUITING NA